GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Guardian Pharmacy Services GRDN · USD

N/A · US listing · 🇺🇸 United States

Compare

49.43

-0.18%

Close of 16 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Guardian Pharmacy Services — daily GRDN Delayed
Market value
$3.13bn
Last close × shares
Volume
369.8k
Shares, 16 Nov 2026
Price to earnings
54.4

About Guardian Pharmacy Services

From its filings with the US Securities and Exchange Commission

SEC filings

Guardian Pharmacy Services is based in Atlanta, Georgia and is incorporated in Georgia. Its shares trade on NYSE under the ticker GRDN. The SEC classifies its business as retail-drug stores and proprietary stores. In the fiscal year to 31 December 2025, it reported revenue of $1.45bn and net income of $49.2m. At that date it held total assets of $412.7m and shareholders' equity of $217.9m.

In its own words

We are a leading, highly differentiated pharmacy services company that provides an extensive suite of technology-enabled services designed to help residents of LTCFs adhere to their appropriate drug regimen, which in turn helps reduce the cost of care and improve clinical outcomes. We emphasize high-touch, individualized clinical, drug dispensing and administration capabilities that are tailored to serve the needs of residents in historically lower acuity LTCFs, such as assisted living facilities (“ALFs”), and behavioral health facilities and group homes (collectively “BHFs”). More than two-thirds of our annual revenue for each of the past three years has been generated from residents of ALFs and BHFs, which are our target markets, while the remainder has been generated primarily from residents of skilled nursing facilities (“SNFs”). Additionally, our robust suite of capabilities enables us to serve residents in all types of LTCFs. We are a trusted partner to residents, LTCFs and health plan payors because we help reduce errors in drug administration, manage and ensure adherence to drug regimens, and lower overall healthcare costs. As of December 31, 2025, our 61 pharmacies, 54 of which are full-service, served approximately 205,000 residents in approximately 8,400 LTCFs across 38 states.

Quoted from its 10-K, filed 11 Mar 2026. Read the filing on SEC.gov ↗

More about Guardian Pharmacy Services →

Latest on Guardian Pharmacy Services

Our reporting

Next results

10 Mar 2027

Due on 10 Mar 2027. Analysts expect earnings of 0.42 a share.

Other N/A listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Guardian Pharmacy Services's ticker?

Guardian Pharmacy Services trades as GRDN on its US listing, under ISIN US40145W1018.

What was Guardian Pharmacy Services's last closing price?

49.43 on 16 Nov 2026. The figure is in USD and is never converted.

When does Guardian Pharmacy Services next report results?

Results are expected on 5 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.